Acquired factor V inhibitor responsive to corticosteroids in a patient with double cancers

13Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

A 70-year-old woman suffering from HCV-related liver cirrhosis was admitted for abnormal bleeding. Laboratory findings included PT at 46.6 sec, APTT at >212 sec, factor V activity of <3%, and factor V inhibitor of 2 BU. Having experienced a persistent bleeding tendency for one month, the patient was started on prednisolone (0.8 mg/kg/day). Within a few days, the inhibitor became undetectable and clinical bleeding disappeared. Although clinical improvement was achieved, she died 6 months after the initial bleeding episode from the progression of a lung cancer. An autopsy revealed squamous cell carcinoma of the lung and hepatocellular carcinoma. © 2007 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Endo, H., Kawauchi, K., Tomimatsu, M., Iga, D., Ogasawara, T., Yasuyama, M., … Aiba, M. (2007). Acquired factor V inhibitor responsive to corticosteroids in a patient with double cancers. Internal Medicine, 46(9), 621–625. https://doi.org/10.2169/internalmedicine.46.6390

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free